Trial Profile
Phase I dose-escalation study of intravenous CMD-193 in subjects with advanced malignant solid tumors
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2007
Price :
$35
*
At a glance
- Drugs CMD 193 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 22 Dec 2005 New trial record.